BreakingChhattisgarhHealthInternationalNationalState

Chhattisgarh can also seeks Permission for Plasma Trials

Now Gujarat seeks permission for plasma trials,After Kerala,from Indian Council of Medical Research (ICMR),for clinical trials for Covid-19 patients

Published By: R-Ajith

Chhattisgarh government can also seek permission for Convalescent Plasma therapy,the way in which the increase number of patient is seen specially from korba District,Katgohara,This may help to treat the patient who are critical or likely to get critical in the state.

For Convalescent Plasma therapy Chhattisgarh Government has seek permission from Indian Council of Medical Research (ICMR),for clinical trials for Covid-19 patients.

The plasma from recovered Covid-19 patient contains source of highly potent antibodies which can help the deteriorating patient to fight back against the dreaded virus.

Gujarat has got permission from Indian Council of Medical Research (ICMR) to start Convalescent Plasma therapy clinical trials for Covid-19 patients in the state,after Kerala.

“The BJ medical college team and a team in SVP hospital Ahmedabad have applied to the ICMR for starting the clinical trials to study the safety and efficacy of convalescent plasma in Covid-19 patients. Right now Kerala has been given the nod for plasma trials and is using that treatment to cure the Covid patients,” said Jayanti Ravi, the principal secretary,the Health and family welfare Department,Gujarat.

Convalescent Plasma therapy involves transfusion of plasma taken from a positive Covid-19 patient who has recovered from the disease and which is transfused into another Covid-19 patient who is critical or likely to get critical.

The plasma from recovered Covid-19 patient contains source of highly potent antibodies which can help the deteriorating patient to fight back against the dreaded virus.

The treatment is showing significant results globally and right now is considered to be the most effective way of treatment against the the global threat.

For this therapy,the plasma is to be collected from the recovered and cured patients of Covid-19.A donor has to be a patient who has fully recovered from the disease,have confirmed negative results and has no symptoms after 14 days of isolation after discharge.

“But for this therapy,the best person to decide about the donor will be the doctors who are treating the patients who are critical,” added Ravi.

Apart from Gujarat,many other states like Maharashtra and Tamil Nadu have also applied to the ICMR for starting the plasma therapy to treat critical virus patients in their states.

Tags
Back to top button
%d bloggers like this: